Complete Case - Dr Chang - MPR

Complete Case – Dr Chang

COMPLETE CASE
 

A CASE-BASED PATHOLOGY PERSPECTIVE TO BIOMARKER TESTING IN ADVANCED NSCLC

Chung-Che (Jeff) Chang, MD, PhD
Medical Director,
Hematology and Molecular Pathology Labs,
Florida Hospital Cancer Institute,
Orlando, Florida

Join Dr. Chang as he uses a case-based approach to discuss strategies to ensure that there is sufficient tissue for histology and molecular characterization in advanced non-small cell lung cancer (NSCLC), and reviews some best practices for optimizing biomarker testing.

CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC

Case Study
Patient Case: Biomarker Testing in Advanced NSCLC


Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC

 

EXPERTS’ INSIGHTS ON BIOMARKER TESTING
IN ADVANCED NSCLC

Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC


Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC


Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC


Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC

Webcasts